feed,title,long_url,short_url
Benzinga,X4 Pharma Highlights New Data Supporting Mavorixafor's Broad Potential In Chronic Neutropenia,https://benzinga.com/general/biotech/22/09/29030451/x4-pharma-highlights-new-data-supporting-mavorixafors-broad-potential-in-chronic-neutropenia,https://bit.ly/3CnFGCl
Benzinga,5 Value Stocks In The Consumer Cyclical Sector,https://benzinga.com/news/22/09/29033518/5-value-stocks-in-the-consumer-cyclical-sector,https://bit.ly/3CdJ8Pw
Benzinga,5 Value Stocks To Watch In The Technology Sector,https://benzinga.com/news/22/09/29033444/5-value-stocks-to-watch-in-the-technology-sector,https://bit.ly/3Slu8Vy
